Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Pioglitazone

EU orphan designation number: EU/3/14/1245   
Active ingredient: Pioglitazone
Indication: Treatment of adrenoleukodystrophy
Sponsor: Minoryx Therapeutics S.L.
Av. Ernest LLuch 32, 08302 Mataró (Barcelona), España

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/02/2014 Orphan designation EMA/OD/170/13 (2014)1220 of 19/02/2014